Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis? Publisher

Moghadasi AN¹ ; Anjidani N² ; Rashvand F³

Show Affiliations

1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Medical Department, Orchid Pharmed Company, Tehran, Iran
3. OrchidLife Patient Support Service, Orchid Pharmed, Tehran, Iran

Source: Frontiers in Emergency Medicine Published:2021

[No abstract available]

Style	Citing Format
MLA	Moghadasi AN, Anjidani N, Rashvand F. "Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?." Frontiers in Emergency Medicine, vol. 5, no. 3, 2021, pp. -.
APA	Moghadasi AN, Anjidani N, Rashvand F (2021). Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?. Frontiers in Emergency Medicine, 5(3), -.
Chicago	Moghadasi AN, Anjidani N, Rashvand F. "Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?." Frontiers in Emergency Medicine 5, no. 3 (2021): -.
Harvard	Moghadasi AN, Anjidani N, Rashvand F (2021) 'Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?', Frontiers in Emergency Medicine, 5(3), pp. -.
Vancouver	Moghadasi AN, Anjidani N, Rashvand F. Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?. Frontiers in Emergency Medicine. 2021;5(3):-.
BibTex	@article{ author = {Moghadasi AN and Anjidani N and Rashvand F}, title = {Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?}, journal = {Frontiers in Emergency Medicine}, volume = {5}, number = {3}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Moghadasi AN AU - Anjidani N AU - Rashvand F TI - Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis? JO - Frontiers in Emergency Medicine VL - 5 IS - 3 SP - EP - PY - 2021 ER -